8-K Announcements
6Material company update
May 5, 2026·SEC
Material company update
Mar 16, 2026·SEC
Material company update
Mar 6, 2026·SEC
Sotera Health Company(SHC)Earnings, Financials & Key Ratios
SHC•NASDAQ
58.6× P/E·Price updated Jun 19, 2026
AboutSotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.Show more
- Revenue$1.16B+5.7%
- EBITDA$303M-34.3%
- Net Income$78M+75.6%
- EPS (Diluted)0.27+68.8%
- Gross Margin55.48%+1.4%
- EBITDA Margin26.06%-37.8%
- Operating Margin33.75%+24.8%
- Net Margin6.7%+66.0%
- ROE15.42%+47.4%
SHC Key Insights
Sotera Health Company (SHC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
- ✗High debt to equity ratio of 3.8x
- ✗Thin 5Y average net margin of 1.0%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SHC Price & Volume
Sotera Health Company (SHC) stock price & volume — 10-year historical chart
Loading chart...
SHC Growth Metrics
Sotera Health Company (SHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years7.3%
3 Years5.05%
TTM7.44%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM374.7%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM369.39%
Return on Capital
10 Years9.08%
5 Years10.8%
3 Years11.4%
Last Year13.33%
SHC Recent Earnings
Sotera Health Company (SHC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
May 5, 2026Metric
Actual
Est
EPS
$0.18+5.9%
$0.17
Rev
$280M+3.4%
$271M
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$0.26+8.3%
$0.24
Rev
$303M+1.3%
$299M
Q4 2025
Nov 4, 2025Metric
Actual
Est
EPS
$0.26+18.2%
$0.22
Rev
$311M+3.9%
$300M
Q3 2025
Aug 8, 2025Metric
Actual
Est
EPS
$0.20+17.6%
$0.17
Rev
$294M-3.5%
$305M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $0.18vs $0.17+5.9% | $280Mvs $271M+3.4% |
| Q1 2026 | Feb 24, 2026 | $0.26vs $0.24+8.3% | $303Mvs $299M+1.3% |
| Q4 2025 | Nov 4, 2025 | $0.26vs $0.22+18.2% | $311Mvs $300M+3.9% |
| Q3 2025 | Aug 8, 2025 | $0.20vs $0.17+17.6% | $294Mvs $305M-3.5% |
Based on last 12 quarters of dataView full earnings history →
SHC Peer Comparison
Sotera Health Company (SHC) competitors in Clinical and Specialty Lab Testing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 STRL | 26.44B | 861.88 | 91.88 | 17.69% | 12.02% | 32.26% | 0.32 | |
 ICLR | 11.18B | 146.00 | 50.34 | -0.37% | 5.98% | 5.2% | 0.39 | |
 CRL | 8.91B | 185.00 | -63.57 | -0.85% | -4.59% | -5.66% | 0.95 | |
 MEDP | 13.14B | 460.20 | 30.12 | 19.97% | 17.19% | 120.89% | 0.55 | |
 PINC | 2.34B | 28.26 | 128.45 | -10.86% | -2.42% | -1.59% | 0.18 | |
 BCO | 4.02B | 97.67 | 20.78 | 4.97% | 3.34% | 45.56% | 12.10 | |
 BRKR | 8.71B | 57.23 | -381.53 | 2.08% | -0.34% | -0.5% | 0.81 | |
 NEOG | 2.03B | 9.31 | -1.85 | -3.2% | -68.47% | -28.64% | 0.44 |
Compare SHC vs Peers
Sotera Health Company (SHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SHC Income Statement
Sotera Health Company (SHC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 746.15M | 778.33M | 818.16M | 931.48M | 1B | 1.05B | 1.1B | 1.16B | 1.19B |
Revenue Growth % | - | 4.31% | 5.12% | 13.85% | 7.75% | 4.54% | 4.88% | 5.74% | 7.44% |
Cost of Goods Sold | 388.9M | 382.9M | 374.59M | 412.81M | 446.68M | 472.13M | 498.15M | 518.08M | 531.97M |
COGS % of Revenue | 52.12% | 49.19% | 45.78% | 44.32% | 44.5% | 45% | 45.27% | 44.52% | - |
Gross Profit | 357.25M▲ 0% | 395.43M▲ 10.7% | 443.57M▲ 12.2% | 518.67M▲ 16.9% | 557M▲ 7.4% | 577.16M▲ 3.6% | 602.29M▲ 4.4% | 645.53M▲ 7.2% | 657.17M▲ 0% |
Gross Margin % | 47.88% | 50.81% | 54.22% | 55.68% | 55.5% | 55% | 54.73% | 55.48% | 55.26% |
Gross Profit Growth % | - | 10.69% | 12.17% | 16.93% | 7.39% | 3.62% | 4.36% | 7.18% | - |
Operating Expenses | 191.34M | 211.83M | 237.55M | 261.94M | 308.65M | 300.47M | 304.67M | 252.76M | 242.59M |
OpEx % of Revenue | 25.64% | 27.22% | 29.04% | 28.12% | 30.75% | 28.64% | 27.69% | 21.72% | - |
Selling, General & Admin | 133.36M | 147.48M | 178.53M | 198.16M | 245.71M | 236.67M | 242.63M | 252.76M | 257.91M |
SG&A % of Revenue | 17.87% | 18.95% | 21.82% | 21.27% | 24.48% | 22.55% | 22.05% | 21.72% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 143.04M | 64.35M | 59.03M | 63.78M | 62.94M | 63.8M | 62.04M | 0 | 1000K |
Operating Income | 80.85M▲ 0% | 183.6M▲ 127.1% | 206.02M▲ 12.2% | 256.73M▲ 24.6% | 248.35M▼ 3.3% | 276.69M▲ 11.4% | 297.63M▲ 7.6% | 392.77M▲ 32.0% | 414.59M▲ 0% |
Operating Margin % | 10.84% | 23.59% | 25.18% | 27.56% | 24.74% | 26.37% | 27.05% | 33.75% | 34.86% |
Operating Income Growth % | - | 127.09% | 12.21% | 24.62% | -3.27% | 11.41% | 7.57% | 31.97% | - |
EBITDA | 227.66M | 330.32M | 349.58M | 407.63M | 393.9M | 434.62M | 461.26M | 303.23M | 517.3M |
EBITDA Margin % | 30.51% | 42.44% | 42.73% | 43.76% | 39.25% | 41.42% | 41.92% | 26.06% | 43.5% |
EBITDA Growth % | - | 45.09% | 5.83% | 16.61% | -3.37% | 10.34% | 6.13% | -34.26% | 11.13% |
D&A (Non-Cash Add-back) | 146.82M | 146.72M | 143.56M | 150.9M | 145.55M | 157.93M | 163.64M | 0 | 102.72M |
EBIT | 167.55M | 156.81M | 176.4M | 249.91M | -162.97M | 248.91M | 278.56M | 303.23M | 356.03M |
Net Interest Income | -143.33M | -157.73M | -215.26M | -74.19M | -80.14M | -142.88M | -164.69M | -155.72M | -114.93M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 143.33M | 157.73M | 215.26M | 74.19M | 80.14M | 142.88M | 164.69M | 155.72M | 149.59M |
Other Income/Expense | -56.63M | -184.51M | -244.88M | -81.02M | -491.46M | -170.66M | -183.75M | -245.27M | -209.64M |
Pretax Income | 24.22M▲ 0% | -916K▼ 103.8% | -38.86M▼ 4142.4% | 175.72M▲ 552.2% | -243.11M▼ 238.4% | 106.03M▲ 143.6% | 113.87M▲ 7.4% | 147.51M▲ 29.5% | 204.94M▲ 0% |
Pretax Margin % | 3.25% | -0.12% | -4.75% | 18.86% | -24.22% | 10.1% | 10.35% | 12.68% | 17.23% |
Income Tax | 30.1M | 19.51M | -1.37M | 58.59M | -9.54M | 54.65M | 69.48M | 69.56M | 87.14M |
Effective Tax Rate % | 124.26% | -2129.8% | 3.52% | 33.35% | 3.92% | 51.54% | 61.01% | 47.16% | 42.52% |
Net Income | -5.87M▲ 0% | -20.85M▼ 255.2% | -38.62M▼ 85.2% | 116.88M▲ 402.7% | -233.57M▼ 299.8% | 51.38M▲ 122.0% | 44.4M▼ 13.6% | 77.95M▲ 75.6% | 117.8M▲ 0% |
Net Margin % | -0.79% | -2.68% | -4.72% | 12.55% | -23.27% | 4.9% | 4.03% | 6.7% | 9.91% |
Net Income Growth % | - | -255.2% | -85.21% | 402.67% | -299.83% | 122% | -13.58% | 75.57% | 374.7% |
Net Income (Continuing) | -5.88M | -20.43M | -37.49M | 117.12M | -233.57M | 51.38M | 44.4M | 77.95M | 117.8M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 1.13M | 1.44M | 2.27M | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -0.02▲ 0% | -0.07▼ 201.7% | -0.14▼ 95.0% | 0.41▲ 392.9% | -0.83▼ 302.4% | 0.18▲ 121.7% | 0.16▼ 11.1% | 0.27▲ 68.8% | 0.41▲ 0% |
EPS Growth % | - | -201.68% | -94.99% | 392.86% | -302.44% | 121.69% | -11.11% | 68.75% | 369.39% |
EPS (Basic) | -0.02 | -0.07 | -0.14 | 0.41 | -0.83 | 0.18 | 0.16 | 0.27 | - |
Diluted Shares Outstanding | 246.15M | 284.42M | 283.25M | 279.38M | 280.1M | 283.22M | 284.91M | 286.42M | 287.62M |
Basic Shares Outstanding | 246.15M | 284.42M | 283.25M | 279.23M | 280.1M | 281.01M | 282.78M | 283.96M | 284.89M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
SHC Balance Sheet
Sotera Health Company (SHC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 312.86M | 252.35M | 315.01M | 345.96M | 645.01M | 557.24M | 526.04M | 613.41M | 585.97M |
Cash & Short-Term Investments | 96.27M | 62.86M | 102.45M | 106.92M | 395.21M | 296.41M | 277.24M | 346.46M | 315.94M |
Cash Only | 96.27M | 62.86M | 102.45M | 106.92M | 395.21M | 296.41M | 277.24M | 346.46M | 315.94M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 141.61M | 111.58M | 131.02M | 134.05M | 155.72M | 175.52M | 165.81M | 176.27M | 176.32M |
Days Sales Outstanding | 69.27 | 52.33 | 58.45 | 52.53 | 56.63 | 61.06 | 55 | 55.29 | 55.83 |
Inventory | 37.6M | 37.4M | 34.09M | 54.29M | 37.15M | 48.32M | 49.16M | 54.38M | 62.84M |
Days Inventory Outstanding | 35.29 | 35.65 | 33.22 | 48 | 30.35 | 37.35 | 36.02 | 38.31 | 39.82 |
Other Current Assets | 12.15M | 10.84M | 10.74M | 11.19M | 16.56M | 20.91M | 16.58M | 36.31M | 30.87M |
Total Non-Current Assets | 2.4B | 2.33B | 2.45B | 2.44B | 2.47B | 2.57B | 2.55B | 2.65B | 2.65B |
Property, Plant & Equipment | 586.44M | 581.95M | 655.78M | 690.74M | 801.01M | 970.95M | 1.06B | 1.16B | 1.18B |
Fixed Asset Turnover | 1.27x | 1.34x | 1.25x | 1.35x | 1.25x | 1.08x | 1.03x | 1.00x | 1.04x |
Goodwill | 1.02B | 1.04B | 1.12B | 1.12B | 1.1B | 1.11B | 1.08B | 1.1B | 1.1B |
Intangible Assets | 766.05M | 696.01M | 643.37M | 598.84M | 491.26M | 416.32M | 317.65M | 288.23M | 279.36M |
Long-Term Investments | 0 | 0 | 13.46M | 9.4M | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 4.15M | 12.24M | 9.3M | 18.34M | 74.55M | 69.72M | 79.58M | 94.36M | 92.82M |
Total Assets | 2.71B▲ 0% | 2.58B▼ 4.7% | 2.76B▲ 7.0% | 2.79B▲ 1.0% | 3.12B▲ 11.8% | 3.13B▲ 0.4% | 3.07B▼ 1.9% | 3.26B▲ 6.2% | 3.24B▲ 0% |
Asset Turnover | 0.28x | 0.30x | 0.30x | 0.33x | 0.32x | 0.34x | 0.36x | 0.36x | 0.37x |
Asset Growth % | - | -4.72% | 7% | 1.02% | 11.77% | 0.41% | -1.88% | 6.24% | 17.09% |
Total Current Liabilities | 143.37M | 123.99M | 140.6M | 161.16M | 791.57M | 230.65M | 191M | 249.58M | 207.8M |
Accounts Payable | 46.35M | 42M | 52.4M | 72.87M | 74.14M | 71.04M | 55.1M | 77.96M | 76.69M |
Days Payables Outstanding | 43.51 | 40.04 | 51.06 | 64.43 | 60.58 | 54.92 | 40.37 | 54.93 | 47.98 |
Short-Term Debt | 15.34M | 16.33M | 0 | 0 | 197.12M | 4.8M | 14.8M | 13.97M | 23.35M |
Deferred Revenue (Current) | 4.62M | 3.63M | 6.06M | 8.67M | 12.14M | 13.49M | 15.1M | 0 | 25.59M |
Other Current Liabilities | 50.65M | 37.34M | 38.8M | 37.21M | 43.12M | 36.93M | 41.12M | 142.74M | 99.37M |
Current Ratio | 2.18x | 2.04x | 2.24x | 2.15x | 0.81x | 2.42x | 2.75x | 2.46x | 2.82x |
Quick Ratio | 1.92x | 1.73x | 2.00x | 1.81x | 0.77x | 2.21x | 2.50x | 2.24x | 2.52x |
Cash Conversion Cycle | 61.06 | 47.93 | 40.61 | 36.1 | 26.4 | 43.49 | 50.64 | 38.67 | 47.67 |
Total Non-Current Liabilities | 2.52B | 3.1B | 2.17B | 2.04B | 1.98B | 2.46B | 2.48B | 2.41B | 2.41B |
Long-Term Debt | 2.19B | 2.8B | 1.82B | 1.74B | 1.75B | 2.22B | 2.21B | 2.13B | 2.12B |
Capital Lease Obligations | 31.54M | 29.88M | 73.88M | 73.89M | 78.53M | 83.88M | 119.75M | 123.74M | 495.21M |
Deferred Tax Liabilities | 171.48M | 137.24M | 121.82M | 134.5M | 68.02M | 64.45M | 69.5M | 71.08M | 248.5M |
Other Non-Current Liabilities | 106.18M | 108.45M | 124.37M | 69.57M | 63.33M | 65.26M | 61.6M | 68.98M | 83.64M |
Total Liabilities | 2.66B | 3.22B | 2.31B | 2.2B | 2.77B | 2.69B | 2.67B | 2.66B | 2.61B |
Total Debt | 2.24B | 2.85B | 1.91B | 1.83B | 2.03B | 2.33B | 2.35B | 2.27B | 2.27B |
Net Debt | 2.14B | 2.79B | 1.81B | 1.72B | 1.64B | 2.03B | 2.07B | 1.93B | 1.95B |
Debt / Equity | 49.19x | - | 4.20x | 3.12x | 5.80x | 5.24x | 5.81x | 3.75x | 3.65x |
Debt / EBITDA | 9.83x | 8.62x | 5.46x | 4.48x | 5.16x | 5.35x | 5.10x | 7.50x | 4.39x |
Net Debt / EBITDA | 9.41x | 8.43x | 5.17x | 4.22x | 4.16x | 4.67x | 4.50x | 6.36x | 3.78x |
Interest Coverage | 1.17x | 0.99x | 0.82x | 3.37x | -2.03x | 1.74x | 1.69x | 1.95x | 2.38x |
Total Equity | 45.49M▲ 0% | -641.13M▼ 1509.4% | 454.57M▲ 170.9% | 586.1M▲ 28.9% | 350.24M▼ 40.2% | 443.73M▲ 26.7% | 404.91M▼ 8.7% | 606.03M▲ 49.7% | 622.5M▲ 0% |
Equity Growth % | - | -1509.36% | 170.9% | 28.93% | -40.24% | 26.7% | -8.75% | 49.67% | 138.02% |
Book Value per Share | 0.18 | -2.25 | 1.60 | 2.10 | 1.25 | 1.57 | 1.42 | 2.12 | 2.16 |
Total Shareholders' Equity | 44.36M | -642.57M | 452.3M | 586.1M | 350.24M | 443.73M | 404.91M | 606.03M | 622.5M |
Common Stock | 2.32M | 2.32M | 2.86M | 2.86M | 2.86M | 2.86M | 2.86M | 2.86M | 0 |
Retained Earnings | -10.42M | -550.51M | -589.13M | -472.25M | -705.82M | -654.44M | -610.04M | -532.09M | -505.5M |
Treasury Stock | 0 | 0 | -34M | -33.55M | -29.77M | -27.18M | -23.43M | -17.01M | 0 |
Accumulated OCI | -109.96M | -94.39M | -93.84M | -83.57M | -106.65M | -92.68M | -208.25M | -109.84M | 0 |
Minority Interest | 1.13M | 1.44M | 2.27M | 0 | 0 | 0 | 0 | 0 | 0 |
SHC Cash Flow Statement
Sotera Health Company (SHC) cash flow — operating, investing & free cash flow history
| Metric | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 119.56M | 149.04M | 120.58M | 281.55M | 277.96M | -147.73M | 224.16M | 287.19M | 229.63M |
Operating CF Margin % | 16.02% | 19.15% | 14.74% | 30.23% | 27.69% | -14.08% | 20.37% | 24.68% | - |
Operating CF Growth % | - | 24.65% | -19.09% | 133.48% | -1.27% | -153.15% | 251.74% | 28.12% | -49.34% |
Net Income | -5.88M | -20.43M | -37.49M | 117.12M | -233.57M | 51.38M | 44.4M | 77.95M | 117.8M |
Depreciation & Amortization | 146.82M | 146.72M | 143.56M | 150.9M | 145.55M | 160.34M | 163.64M | 0 | 127.18M |
Stock-Based Compensation | 6.94M | 6.88M | 10.99M | 13.87M | 21.21M | 32.24M | 36.78M | 0 | 23.77M |
Deferred Taxes | -45.32M | -18.99M | -23.36M | -3.72M | -73.96M | 3.45M | 9.43M | 0 | -9.02M |
Other Non-Cash Items | 12.96M | 43.21M | 38.68M | 15.96M | 9.49M | 8.15M | 12.55M | 181.2M | 96.33M |
Working Capital Changes | 4.04M | -8.35M | -11.79M | -12.59M | 409.23M | -403.29M | -42.63M | 28.04M | -16.59M |
Change in Receivables | -2.91M | 11.76M | 1.94M | -15.51M | -12.55M | -21.72M | 2.22M | 7.15M | -51K |
Change in Inventory | -7.04M | -282K | 3.78M | -20.25M | 14.44M | -9.97M | -4.75M | -2.38M | 422K |
Change in Payables | 15.13M | -8.97M | -6.02M | 19.76M | 1.11M | -5.33M | -6.64M | 5.18M | 1.89M |
Cash from Investing | 96.64M | -57.26M | -158.69M | -159.83M | -181.9M | -214.91M | -179M | -135.14M | -115.26M |
Capital Expenditures | -72.61M | -57.26M | -53.51M | -102.16M | -182.38M | -214.97M | -179.07M | -138.02M | -118.1M |
CapEx % of Revenue | 9.73% | 7.36% | 6.54% | 10.97% | 18.17% | 20.49% | 16.27% | 11.86% | 9.93% |
Acquisitions | 162.82M | 0 | -105.19M | -56.97M | 450K | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - |
Other Investing | 6.43M | 0 | 0 | -701K | 32K | 69K | 74K | 2.87M | 2.84M |
Cash from Financing | -191.86M | -126.03M | 73.43M | -117.29M | 197.76M | 265.96M | -50.56M | -100.53M | -90.4M |
Debt Issued (Net) | -14.63M | 583.52M | -1.03B | -100M | 200M | 297.5M | -11.76M | -86.1M | -85.89M |
Equity Issued (Net) | 0 | 0 | 1.12B | -1.43M | -393K | -4.09M | -4.43M | 0 | -54K |
Dividends Paid | -175.84M | -691.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -34M | -1.43M | -393K | -4.09M | -4.43M | 0 | -54K |
Other Financing | -1.38M | -18.38M | -21.2M | -15.85M | -1.85M | -27.45M | -34.38M | -14.43M | -4.46M |
Net Change in Cash | 20.67M▲ 0% | -33.76M▼ 263.3% | 39.43M▲ 216.8% | 4.47M▼ 88.7% | 289.37M▲ 6373.6% | -94.64M▼ 132.7% | -22.79M▲ 75.9% | 67.59M▲ 396.6% | 9.86M▲ 0% |
Free Cash Flow | 46.95M▲ 0% | 91.78M▲ 95.5% | 67.08M▼ 26.9% | 179.38M▲ 167.4% | 95.58M▼ 46.7% | -362.71M▼ 479.5% | 45.09M▲ 112.4% | 149.18M▲ 230.8% | 111.53M▲ 0% |
FCF Margin % | 6.29% | 11.79% | 8.2% | 19.26% | 9.52% | -34.57% | 4.1% | 12.82% | 9.38% |
FCF Growth % | - | 95.49% | -26.92% | 167.42% | -46.72% | -479.47% | 112.43% | 230.81% | 7.2% |
FCF per Share | 0.19 | 0.32 | 0.24 | 0.64 | 0.34 | -1.28 | 0.16 | 0.52 | 0.39 |
FCF Conversion (FCF/Net Income) | -20.37x | -7.15x | -3.12x | 2.41x | -1.19x | -2.88x | 5.05x | 3.68x | 0.95x |
Interest Paid | 138.85M | 151M | 211.28M | 58.77M | 75.85M | 173.84M | 179.92M | 0 | 55.3M |
Taxes Paid | 68.61M | 44.61M | 23.99M | 52.01M | 75.5M | 50.21M | 65.83M | 0 | 19.99M |
SHC Key Ratios
Sotera Health Company (SHC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | -8.5% | 22.46% | -49.89% | 12.94% | 10.46% | 15.42% | 20.57% |
Return on Invested Capital (ROIC) | 6.36% | 7.01% | 8.43% | 8.68% | 9.3% | 9.01% | 11.76% | 12.24% |
Gross Margin | 50.81% | 54.22% | 55.68% | 55.5% | 55% | 54.73% | 55.48% | 55.26% |
Net Margin | -2.68% | -4.72% | 12.55% | -23.27% | 4.9% | 4.03% | 6.7% | 9.91% |
Debt / Equity | - | 4.20x | 3.12x | 5.80x | 5.24x | 5.81x | 3.75x | 3.65x |
Interest Coverage | 0.99x | 0.82x | 3.37x | -2.03x | 1.74x | 1.69x | 1.95x | 2.38x |
FCF Conversion | -7.15x | -3.12x | 2.41x | -1.19x | -2.88x | 5.05x | 3.68x | 0.95x |
Revenue Growth | 4.31% | 5.12% | 13.85% | 7.75% | 4.54% | 4.88% | 5.74% | 7.44% |
Related:SHC Dividend History·SHC Revenue History·SHC Price History·SHC P/E History·SHC Financial Ratios·SHC Institutional Holders
SHC SEC Filings & Documents
Sotera Health Company (SHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
SHC Frequently Asked Questions
Sotera Health Company (SHC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Sotera Health Company (SHC) reported $1.19B in revenue for fiscal year 2025. This represents a 59% increase from $746.1M in 2018.
Sotera Health Company (SHC) grew revenue by 5.7% over the past year. This is steady growth.
Yes, Sotera Health Company (SHC) is profitable, generating $117.8M in net income for fiscal year 2025 (6.7% net margin).
Dividend & Returns
Sotera Health Company (SHC) has a return on equity (ROE) of 15.4%. This is reasonable for most industries.
Sotera Health Company (SHC) generated $111.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.